New Delhi: Pharmaceutical giant AstraZeneca has announced the global withdrawal of its Covid-19 vaccine. The company cited a surplus of newer vaccine options as the primary reason behind this decision.
AstraZeneca has voluntarily withdrawn the “marketing authorization” for the vaccine within the European Union, with similar applications expected to be made in other countries where the vaccine was previously approved.
This decision comes amidst ongoing legal battles faced by AstraZeneca, including allegations linking its vaccine, developed in collaboration with the University of Oxford, to fatalities and severe injuries, notably Thrombosis with Thrombocytopenia Syndrome (TTS).
However, the company has clarified that the withdrawal is not directly linked to ongoing court cases or its admission of TTS side effects. Instead, AstraZeneca attributed the decision to commercial reasons and a decline in demand for the vaccine.
“As multiple variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines,” stated AstraZeneca in a released statement.
Bhubaneswar: Recognising their gold medal-winning performances at the 2026 Asian Games in Japan, Odisha Chief…
Bhubaneswar: Two school-going sisters from Odisha have used a multiplication table to deliver a social…
Bhubaneswar: The Satwalipi Committee on Mahaprabhu Lingaraj Temple has submitted its third interim report to…
Bhubaneswar: Odisha will organise a state-level summit to finalise priorities and accelerate the implementation of…
Bhubaneswar: The Housing and Urban Development Department has asked Urban Local Bodies (ULBs) across Odisha…
Bhubaneswar: From exploring ancient temples and the story of Odisha’s capital city to discovering local…
